Filing metadata

Accession number
0001415889-25-001160
Form type
Form 4
Filer
Quince Therapeutics, Inc.
CIK
CIK 1662774
Filed
Jan 08, 2025
Reporting period
Jan 02, 2025
Description
Insider transaction

Explore SEC Filings Hub